期刊文献+

聚合酶活性信号检测地高辛方法的建立

Establishment of a digoxin detection method by polymerase Activity signal
下载PDF
导出
摘要 目的建立以聚合酶活性信号为检测对象的反应体系,使用具有高灵敏度和精密度的均相分析方法,实现地高辛血药浓度的自动化检测。方法设计特异的DNA模板及其引物,引物上特定位点连接有Digoxingenin-11-dUTP(Dxin),使得样品中地高辛(Dig)与引物上的Dxin在抗Dig抗体存在时形成竞争反应,影响DNA聚合酶与引物结合,从而根据合成的双链量即可检测出样品Dig浓度。结果选择D2p作为Dxin在引物上的结合位点,17nmol/L模板及引物浓度、33nmol/L的抗Dig抗体浓度。试剂可报告范围为0.3~39.0ng/mL,CV〈10%。结论聚合酶活性信号检测技术可以实现高灵敏度的地高辛均相分析。 Objective To establish a reaction system with the polymerase activity signal as the detection object and to realize the automatic detection of digoxin(Dig)blood concentration by using the homogeneous phase assay method with high sensitivity and high precision.Methods The specific DNA template and its primer which conjugated with Digoxingenin-11-dUTP(Dxin)at specific site were designed.Dig in serum sample was formed the competing reaction with Dxin on the primer when anti-Digoxin antibody existed,which influenced the combination of DNA polymerase with primer,thus the dig content in the sample could be detected according to the synthesized double chain amount.Results D2 p as the binding site of Dxin on the primer,17nmol/L template,primer concentration and 33nmol/L anti-Dig concentration were selected.The reportable range of reagent was 0.3-39.0ng/mL,CV〈10%.Conclusion The polymerase signal detection technology can realize the Dig homogeneous phase analysis with high sensitivity.
作者 袁矜 夏东元
出处 《检验医学与临床》 CAS 2016年第5期633-634,637,共3页 Laboratory Medicine and Clinic
关键词 地高辛 DNA聚合酶 均相反应 digoxin DNA polymerase homogeneous reaction
  • 相关文献

参考文献11

  • 1Ahmed A. Digoxin and reduction in mortality and hospi talization in geriatric heart failure:importance of low do ses and low serum coneentrations[J].J Gerontol,2007,62 (3) :323- 329.
  • 2Palacios Zabalza I,Corcostegui-Santiago B, Peral-Aguirre- gotia J. Combination treatment with digoxin antibodies and plasmapheresis for tile management of digoxin toxici- ty in a patient with renal failure[J].Farmacy Hosp,2013, 37(2) :170-172.
  • 3Ikeda J, Ichiki T, Matsuura H, et al. Deletion of phd2 in myeloid lineage attenuates hypertensive cardiovascular re modeling[J]. J Am tteart Assoc,2013,2(3) :18-24.
  • 4林红.儿童地高辛血药浓度监测及影响因素分析[J].儿科药学杂志,2010,16(3):31-32. 被引量:12
  • 5Gheorghiade M, Harinstein ME, Filippatos GS. Digoxin for the treatment of chronic and acute heart failure syn- dromes[J]. Acute Cardiac care, 2009,11 (2) :83-87.
  • 6Xu R,I.in G,Wang W,et al. Application of an EI.ISA-elu- tion assay to dissociate digoxin-antibody complexes in immunoaffinity chromatography[J]. Scand J lmmunol,2010, 71(1) :55-60.
  • 7Wagner AD, Kolb JM, Ozbal CC, et al. Ultrafast mass spectrometry based bioanalytical method for digoxin sup- porting an in vitro P glycoprotein (P gp) inhibition screen[J]. Rapid Commun Mass Spectr, 2011,25(9): 1231-1240.
  • 8贾欣珠.地高辛血药浓度监测及分析[J].基层医学论坛,2011,15(19):584-586. 被引量:5
  • 9Omidfar K, Kia S, Kashanian S, et al. Colloidal nanogold- based immunochromatographic strip test for the detection of digoxin toxicity[J]. Appl Biochem Biotech, 2010, 160 (3) :843-855.
  • 10Yamada T, Suzuki K, Iguchi K, et al. Interference between eplerenone and digoxin in fluorescence polarization immu- noassay, microparticle enzyme immunoassay, and affinity column-mediated immunoassay [J].Ther Drug Monit, 2010,32(6):774 -777.

二级参考文献15

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部